Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JINS HoldingsJNDOF +68.92%96 ROC (Joel Greenblatt) % is 68.15% as of Feb. 2026, which is 58% above its 10-year median of 43.18. GuruFocus rates JNDOF with a GF Score™ of 96/100 and a GF Value™ of $42.68. Among 840 Medical Devices & Instruments companies, JINS Holdings ranks better than 94.76% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. JINS Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2026 was 68.15%.
The historical rank and industry rank for JINS Holdings's ROC (Joel Greenblatt) % or its related term are showing as below:
JNDOF'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 20.36 Med: 43.18 Max: 96.16
Current: 71.84
During the past 13 years, JINS Holdings's highest ROC (Joel Greenblatt) % was 96.16%. The lowest was 20.36%. And the median was 43.18%.
JNDOF's ROC (Joel Greenblatt) % is ranked better than 94.76% of 840
companies
in the Medical Devices & Instruments industry
Industry Median: 4.24
vs JNDOF: 71.84
JINS Holdings's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 19.70% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
JINS Holdings ROC (Joel Greenblatt) % Related Terms
JINS Holdings ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for JINS Holdings's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JNDOF vs ISRG, BDX, MDLN: ROC (Joel Greenblatt) % Comparison
For the Medical Instruments & Supplies subindustry, JINS Holdings's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JINS Holdings ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JINS Holdings's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where JINS Holdings's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Feb. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 68.15% mean?
JINS Holdings (JNDOF) has a ROC (Joel Greenblatt) % of 68.15% as of Feb. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on JINS Holdings and its competitors. This is 58% above median its historical median of 43.18. Over the past decade, JINS Holdings' ROC (Joel Greenblatt) % has ranged from 20.36 to 96.16. According to the industry distribution chart, JINS Holdings ranks #44 out of 840 companies in the Medical Devices & Instruments industry, placing it in the top 5.2%.
Is JINS Holdings' ROC (Joel Greenblatt) % too high?
JINS Holdings' current ROC (Joel Greenblatt) % of 68.15% is 58% above median its 10-year median of 43.18. Over the past 10 years, this metric has ranged from a low of 20.36 to a high of 96.16. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.24. JINS Holdings' value of 68.15% is 1507.3% above this industry median. Based on the distribution chart, JINS Holdings ranks #44 out of 840 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, JINS Holdings has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does JINS Holdings' ROC (Joel Greenblatt) % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JINS Holdings ranks #44 out of 840 companies for ROC (Joel Greenblatt) %. This places JINS Holdings in the top 5% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 4.24. JINS Holdings' value of 68.15% is 1507.3% above this benchmark. Historically, JINS Holdings' own ROC (Joel Greenblatt) % has ranged from 20.36 to 96.16 over the past decade. While the company's 10-year median is 43.18 vs. the industry median of 4.24, JINS Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.24, based on 840 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JINS Holdings's current ROC (Joel Greenblatt) % of 68.15% is 1507.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on JINS Holdings and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JINS Holdings's current ROC (Joel Greenblatt) % is 68.15%, which is 58% above median its own 10-year median of 43.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JINS Holdings stock overvalued right now?
JINS Holdings (JNDOF) has a current ROC (Joel Greenblatt) % of 68.15%. The stock's GF Value™ is $42.68, compared to a current price of $38.43 — trading 10% below its estimated fair value. The current ROC (Joel Greenblatt) % is 68.15%, which is 58% above median its 10-year median of 43.18 and 1507.3% above the Medical Devices & Instruments industry median of 4.24. JINS Holdings' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For JINS Holdings (JNDOF), the current ROC (Joel Greenblatt) % is 68.15% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JINS Holdings (JNDOF) Overvalued in 2026?
Based on GuruFocus' analysis, JINS Holdings stock appears to be undervalued.
The current stock price of $38.43 is trading 10% below its estimated GF Value™ of $42.68.
Key valuation signals for JNDOF:
ROC (Joel Greenblatt) %: 68.15% (58% above median its 10-year median of 43.18)
GF Value™: $42.68 vs. price of $38.43 (10% below fair value)
Industry Position: 1507.3% above the Medical Devices & Instruments median (#44 of 840)
No single metric tells the full story. See the JNDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JINS Holdings Inc is an eyewear retailer that manufactures and sells private-label fashion eyeglasses and sunglasses. It offers prescription eyeglasses and nonprescription fashion or functional eyeglasses. Its inventory is on the shelves, and it charges flat rates with generally no additional charges or options for lens features. Jin has more than 300 stores in Japan as well as locations in China, Taiwan, and the United States. Stores are typically located in high-traffic areas such as shopping centers, malls, and train stations.
96GF Score
Get the complete analysis for JNDOF
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JNDOF has been successfully added to your 
